Compare TLSA & LFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TLSA | LFS |
|---|---|---|
| Founded | 2013 | 2001 |
| Country | United Kingdom | Japan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 182.7M | 152.3M |
| IPO Year | 2000 | 2025 |
| Metric | TLSA | LFS |
|---|---|---|
| Price | $1.48 | $3.06 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 414.9K | 111.1K |
| Earning Date | 01-01-0001 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 41.71 |
| EPS | N/A | ★ 0.11 |
| Revenue | N/A | ★ $77,480,718.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $26.86 |
| Revenue Growth | N/A | ★ 15.14 |
| 52 Week Low | $0.63 | $1.58 |
| 52 Week High | $2.60 | $12.49 |
| Indicator | TLSA | LFS |
|---|---|---|
| Relative Strength Index (RSI) | 39.51 | N/A |
| Support Level | $1.45 | N/A |
| Resistance Level | $1.62 | N/A |
| Average True Range (ATR) | 0.16 | 0.00 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 35.58 | 0.00 |
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
Leifras Co Ltd is a sports and social business company dedicated to youth sports and community engagement. It provide services related to the organization and operations of sports schools and sports events for children.